title: In vivo post-contrast 1H-MRS evaluation of malignant and benign breast lesions: a meta-analysis.
abstract: The aim of this study is to perform a meta-analysis to evaluate the diagnostic performance of the in vivo post-contrast proton magnetic resonance spectroscopy (MRS) for benign/malignant discrimination of focal breast lesions. Sixteen studies with a total of 661 malignant breast lesions and 388 benign breast lesions were included. The pooled sensitivity and specificity of post-contrast 1H-MRS were 74 % (95 % confidence interval (CI) 70-77 %) and 78 % (95 % CI 73-82 %), respectively. The positive likelihood ratio (PLR) and the negative likelihood ratio (NLR) were 4.00 (95 % CI 2.74-5.84) and 0.25 (95 % CI 0.17-0.37), respectively. From the fitted summary receiver operating characteristics curve (SROC), the AUC and Q* index were 0.89 and 0.83. Publication bias was present (t = 2.43, P = 0.029). Meta-regression analysis suggested that neither threshold effect nor evaluated covariates including method of choline analysis, strength of field, pulse sequence, repetition time (TR), and time interval were sources of heterogeneity (all P values >0.05). In vivo post-contrast 1H-MRS was useful for differentiation between malignant and benign focal breast lesions. However, pooled diagnostic measures might be overestimated. The standardization of the acquisition protocol as well as the post-processing method for post-contrast proton MRS need to be established for the future study.
authors.affiliation: Department of Medical Imaging, Guangzhou Nansha Central Hospital, Guangzhou First People's Hospital, Guangzhou Medical University, Guangzhou, Guangdong Province, 510150, People's Republic of China.
authors.forename: Jieying
authors.initials: J
authors.lastname: Tan
authors.forename: Li
authors.initials: L
authors.lastname: Xu
authors.forename: Wenqing
authors.initials: W
authors.lastname: Yao
authors.forename: Yun
authors.initials: Y
authors.lastname: Wan
authors.forename: Shuqin
authors.initials: S
authors.lastname: Zhou
authors.forename: Sherman Xuegang
authors.initials: SX
authors.lastname: Xin
mesh_terms: D001943:Breast Neoplasms / Q000175:diagnosis*; D003287:Contrast Media; D005260:Female; D006801:Humans; D009682:Magnetic Resonance Spectroscopy; D012372:ROC Curve
chemical_list: D003287:Contrast Media